Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Sacks

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Nature Medicine|December 10, 1998
Vaccine requirements for sustained cellular immunity to an intracellular parasitic infectionS Gurunathan, C Prussin, D L Sacks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1991
Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophagesA Descoteaux, S J Turco, D L Sacks, et al.
The Journal of Experimental Medicine|March 1, 1984
Dichotomy in the tissue origin of schistosome acquired class I and class II major histocompatibility complex antigensA Sher, D L Sacks, A J Simpson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Molecular mimicry of a carbohydrate epitope on a major surface glycoprotein of Trypanosoma cruzi by using anti-idiotypic antibodiesD L Sacks, L V Kirchhoff, S Hieny, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1983
Late metastatic Leishmaniasis in the mouse. A model for mucocutaneous diseaseA Barral, E A Petersen, D L Sacks, et al.
Molecular Microbiology|March 7, 1998
Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63)P B Joshi, D L Sacks, G Modi, et al.
Infection and Immunity|April 1, 1982
Incubation of trypanosome-derived mitogenic and immunosuppressive products with peritoneal macrophages allows recovery of biological activities from soluble parasite fractionsD L Sacks, G Bancroft, W H Evans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathwayD L Sacks, P A Scott, R Asofsky, et al.
The EMBO Journal|October 1, 1992
Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stageM J McConville, S J Turco, M A Ferguson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Growth cycle-dependent generation of complement-resistant Leishmania promastigotesE D Franke, P B McGreevy, S P Katz, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Nature Medicine|December 10, 1998
Vaccine requirements for sustained cellular immunity to an intracellular parasitic infectionS Gurunathan, C Prussin, D L Sacks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1991
Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophagesA Descoteaux, S J Turco, D L Sacks, et al.
The Journal of Experimental Medicine|March 1, 1984
Dichotomy in the tissue origin of schistosome acquired class I and class II major histocompatibility complex antigensA Sher, D L Sacks, A J Simpson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Molecular mimicry of a carbohydrate epitope on a major surface glycoprotein of Trypanosoma cruzi by using anti-idiotypic antibodiesD L Sacks, L V Kirchhoff, S Hieny, et al.
The American Journal of Tropical Medicine and Hygiene|March 1, 1983
Late metastatic Leishmaniasis in the mouse. A model for mucocutaneous diseaseA Barral, E A Petersen, D L Sacks, et al.
Molecular Microbiology|March 7, 1998
Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63)P B Joshi, D L Sacks, G Modi, et al.
Infection and Immunity|April 1, 1982
Incubation of trypanosome-derived mitogenic and immunosuppressive products with peritoneal macrophages allows recovery of biological activities from soluble parasite fractionsD L Sacks, G Bancroft, W H Evans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1984
Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathwayD L Sacks, P A Scott, R Asofsky, et al.
The EMBO Journal|October 1, 1992
Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stageM J McConville, S J Turco, M A Ferguson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Growth cycle-dependent generation of complement-resistant Leishmania promastigotesE D Franke, P B McGreevy, S P Katz, et al.
Pageof 8